Project Details
Description
PR172072-Randomized Trial to Evaluate Mirasol Whole Blood Pathogen Reduction Technology System to Reduce Malaria and Other Transfusion Transmitted Infections PR172072-Randomized Trial to Evaluate Mirasol Whole Blood Pathogen Reduction Technology System to Reduce Malaria and Other Transfusion Transmitted Infections
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/18 → 9/29/22 |
Funding
- DOD-ARMY: Army Medical Research Acquisition Activity (USAMRAA) : $720,527.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.